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ABSTRACT 
Objective: Objective of the study was to develop tamoxifen citrate immediate release pellets by hot-melt extrusion (HME) and to study the effect of 
various formulation and process variables.  
Methods: Pellets were prepared by HME technique. Effect of various parameters such as the concentration of ethylcellulose, PEG 6000, 
croscarmellose sodium, and spheronization speed were studied by using Central Composite Design. Pellets were evaluated for theoretical yield (%), 
mean pellet size (mm), sphericity (pellips), friability (%), porosity (%), mechanical crushing force (n), and dissolution efficiency. Optimized 
formulation was studied for compatibility study using IR, DSC, and XRD, SEM, In vitro drug release. In vitro Cell Cytotoxicity and Viability Assay were 
carried out using MCF-7 (human breast cancer cells) by MTT assay. 
Results: Results showed that a variable such as the amount of Methyl Cellulose, PEG 6000 and Spheronization speed showed positive correlation and 
amount of Croscarmellose sodium showed a negative correlation with dependent variables. Optimized formulation showed Korsmeyer Peppas model as 
a mechanism of drug release. Value of n was found to be in between 0.77+0.04, which reveals that, release mechanism of the drug as non-Fickian 
transport (0.45<n<0.89). MTT results of MCF-7 cells showed that optimized immediate release pellets have maximum cytotoxicity at 80 µg/ml. 
Conclusion: Study concluded that HME method and materials i.e. PEG 6000 and methylcellulose can effectively use to get immediate release of 
tamoxifen citrate so as to increase dissolution rate and cytotoxic effect.  
Keywords: Tamoxifen citrate, Pellets, Hot-melt extrusion, Immediate release, Central composite design 




One of the greatest difficulties confronted today by the pharmaceutical 
industries lies in empowering the conveyance of inadequately water-
soluble drug. Solubility is a basic physicochemical property of the 
drug, as it legitimately identifies with a bioavailability of the atom 
inside in the body. Tamoxifen citrate (TMC) is BCS class II drug 
commercially converted to salt form as citrate to increase so as to 
increase its aqueous solubility and efficacy. Although it is in the salt 
form its solubility in water is limited as it has a higher melting point 
(146 ᵒC) which inhibits its dissolution [1].  
Hot-Melt Extrusion (HME) is an effective technique for delivering 
solid molecular dispersions with significant advantages over 
solvent-based technique such as spray drying and co-precipitation. 
HME is successfully used to develop sustained, modified, and 
targeted drug delivery. HME technique is presently used in 
pharmaceutical industries for various applications because of its 
numerous advantages over traditional methods [2]. 
TMC is a poorly water-soluble drug having pKa 8 and equilibrium 
solubility in water at 37 °C is 0.5 mg/ml. Hence dissolution from its 
dosage forms is also low and is a limiting step in the absorption 
process. It was reported that the dissolution of TMC can be 
enhanced to some level by preparing micro-emulsions and solid 
lipid nanoparticles [3-6]. Enhanced dissolution of TMC using water-
soluble polymer has not yet reported in the literature. Thus, we 
focused on the present study on enhancing the dissolution power of 
drug by Hot-Melt Extrusion (HME) technique. The objective of 
present work was to study the effect of different variables such as 
the concentration of Methyl Cellulose, PEG 6000, Croscarmellose 
Sodium and Spheronization Speed on dissolution efficiency.  
MATERIALS AND METHODS 
Materials 
Tamoxifen Citrate was received as a gift sample from USV Private 
Limited Govandi, Mumbai, India. Polyethylene glycol 6000 and 
Methylcellulose were generously gifted by Merck Specialities Pvt. 
Ltd, Mumbai., India. Citric acid and Croscarmellose sodium were 
purchased from Qualigens Fine Chemicals and Spectrum Chemical 
Mfg. Corp. Mumbai, India respectively.  
Methods 
Preparations of pellets by hot-melt extrusion technique 
Central Composite Design (CCD) with quadratic and 2FI as 
design model was used to design experiment. Formulation 
batches with different variable are shown in table 1. The 
required quantities of drug and excipients i.e. PEG 6000, 
Methylcellulose, anhydrous citric acid (20%), Avicel PH 101, 
Croscarmellose sodium were passed individually through 40 # 
ASTM stainless steel sieve. Drug, excipients and each of the 
polymers was uniformly mixed in a lab-scale planetary mixer 
(Umang Pharmatech Pvt. Ltd.) for 10 min. Then blend was 
transferred to 16 mm co-rotating twin screw melt extruder and 
operated at temperatures between 70 and 140 °C, depending on 
the processability of the formulation. The screw speed was set to 
20 rpm, motor load to 0.700 drive amperes, and the pressure 
didn’t exceed 200 PSI. Screen for extrusion used was of 0.5 mm 
perforations diameter and 1.5 mm thickness. Extrudates were 
converted to spherical pellets using spheronizer (Cronimach, 
India) operated at 700 rpm. The obtained extrude product was 
further spheronised to obtain spherical pellets. Formed pellets 
were again blended with Magnesium stearate for 10 min [7, 8].  
Characterization of pellets prepared by HME 
Mean pellet size 
200 g of sample was used for mean pellet size analysis. The pellets 
were sieved through sieves having aperture sizes from 250 to 2800 
mm on mechanical sieve shaker (EMS-8, Electrolab, India) for 10 
min. Geometric mean pellet size and size distribution were 
calculated using the equation given by Heng et al. [7] 
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Usable yield (% theoretical) 
The usable yield of the pellets was determined by sieve analysis, 
using a sieve shaker (EMS-8, Electrolab, India) equipped with (600-
2360 μm) sieves for 5 min. at an amplitude of 2 mm. This size 
fraction was used as a percent of total pellet weight [8, 9]. 
% Yield =
Weight of pellet 
Weight of Polymer + Weight of Drug
x100 
Sphericity and shape analysis 
It is determined using an image analysis system. Photomicrographs 
of pellets were taken with a digital camera linked with a 
stereomicroscope system a stereomicroscope Leica S4E (Germany). 
Around 50 pellets were analyzed from every batch. The shape of 






P is the perimeter and dmax is the maximum diameter of the pellet, 
calculated directly by using image analysis software. 
Abrasion resistance (friability) 
The friability of the pellets (#14/22 fraction) was determined. 
Weighed amount pellets were subjected to test along with 24 steel 
balls (diameter about 2 mm) in a Roche friabilator for 100 
revolutions at 25 rpm and then sieved through a #22 sieve. The 
percent weight loss was then calculated [8]. 
Porosity 
Pellet porosity is of great interest since more porous dosage forms 
usually exhibit faster drug release rates. Porous systems have more 
channels for water to enter and to dissolve the drug [12-14]. The 
effective porosity describes the space occupied by air inside a 
dosage form prior to the dissolution of the drug. Pellet porosity was 
calculated using the following equation, for percent effective 
porosity [12, 13]. 
% ε = [(ρt– ρb)/ρb] x 100 
Where, 
ε = effective porosity, ρt = true density and ρb = bulk density.  
Mechanical crushing force 
Tablet strength tester (EH 01, Electrolab, India) was used to 
measure mechanical crushing force. 20 pellets from the modal size 
fraction of each formulation were evaluated for their diametral 
crushing force [15, 16]. 
Densities  
The bulk density was determined using the graduated glass cylinder. 
The tapped density was determined using a tapped density test 
apparatus (USP, 2007).  
Flow property and compressibility studies 
Flowability of the pellets was assessed by determining the Carr’s 
index (compressibility index), Hausner’s ratio and angle of repose 
(Powder Flow 1174) [7, 8]. 
Drug content 
The tamoxifen citrate pellets were assayed as per US 
pharmacopoeial method, using HPLC [1]. 
In vitro drug release 
The USP basket apparatus type I was used for all the in vitro 
dissolution studies. 900 ml of 0.02 N HCl was used as dissolution 
media, at 100 rpm and 37±0.5◦C. 5 ml of the samples were taken at a 
suitable time interval (5, 10, 20, 30, 40, 50, 60, min.) and filtered 
through a 0.45 mm Millipore filter. Samples were assayed by the 
HPLC method [17, 18]. 
Compatibility study 
Drug-excipient compatibility study was carried out using FTIR, DSC, 
and XRD. 
Scanning electron microscopy (SEM) 
Morphological examination of the surface was carried out using an 
SEM. SEM of pellets was obtained using JEOL JSM 6100 (JEOL, Japan).  
Stability studies 
The immediate-release pellets were subjected to stability studies. 
Pellets were filled into an empty hard gelatin capsule and were 
stored in tightly closed HDPE containers and in the aluminum pack. 
The stability studies were carried out at 40 °C±2 °C/75% RH±5% as 
per ICH guidelines (ICH, 2003). The stability samples were analyzed 
at 1, 2, 3 and 6 mo for assay and dissolution studies. F2 value was 
calculated using following equation to ensure the equivalence with 
initial samples [19]. 




In vitro cell cytotoxicity and viability assay 
Cell culture experiment 
Cell line study was performed on (MCF-7) (human breast cancer 
cells) procured from National Center for Cell Science (NCCS), Pune, 
India. Cells were maintained in T-25 tissue culture grade flask and 
cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS), 
2 mmol glutamine, 1% penicillin and streptomycin mix to 
discourage growth of microorganisms and maintained in humidified 
atmosphere at 5 % CO2 at 37±0.5 °C grown to 80% confluence in 
tissue culture humidified environment [28]. 
Methyl thiazole tetrazolium (MTT) assay 
Day 1: 1×105cells/ml was added in 96 well plates (cell count was 
taken on Neubauer's chamber). Then the plate was incubated at 
37°C in a CO2 incubator for 24 h. 
Day 2: After 24 h incubation plate was observed under an inverted 
microscope. A sterile test sample of scaffolds was added in triplicate. 
100 µl extract media of scaffold sample was added in triplicate. After 
this plate was incubated at 37°C in a CO2 incubator for 24 h. 
Day 3: After 24 h incubation plate was observed under an inverted 
microscope. A test sample of scaffolds was removed and 100 µl fresh 
DMEM medium was added. Then10 µl of 5 mg/ml MTT reagent was 
added in each well. Plate wrapped in aluminum foil was incubated 
for 4 h in a CO2 incubator. After 4 h incubation plate was removed 
and observed under an inverted microscope and photographs were 
taken. After 1 hr absorbance was measured at 492 nm on 96 well 
Plate reader. Cell viability (%) and cytotoxicity (%) was calculated 
using the following formula:  
Cell Viability (%) = [A]test/[A]control ×  100 
Where, [A]test is the absorbance of the test sample and [A]control is 
the absorbance of control samples. 
Cytotoxicity (%) = 100– Cell viability (%) 
Concentration Tested: 1, 10, 20, 40, 80 and 100 µg/ml for the 
sample.  
RESULTS AND DISCUSSION 
Formulation and characterization of immediate-release pellets 
Formulation batches and results of characterization are summarized 
in table 1.  
Statistical analysis of the data and validation of the 
optimization model 
The design expert version 7.0 software (Minnesota, USA) was used 
in the current study for the generation and evaluation of the 
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statistical experimental design. The independent variables 
concentration of methylcellulose (%), PEG 6000, Croscarmellose 
Sodium (%) and Spheronization Speed (rpm) of pellet obtained by 
using melt extrusion and spheronization technique against 
dependent variables i.e. Theoretical Yield (%), Mean Pellet Size 
(mm), Sphericity (pellips), Friability (%), Porosity (%), Mechanical 
Crushing Force(N) and dissolution efficiency (DE) was studied 
(table 2). 
 

























































































































































































































































































































































*All values represent mean±standard deviation (n=3)  
Sathesh et al. 
Int J App Pharm, Vol 11, Issue 5, 2019, 111-124 
 
114 
Table 2: Design summary for 30 runs with quadratic and 2FI as design models 
Factor Name Units Type Low actual High actual Low coded High coded Mean Std. dev. 
A Amount of Methyl Cellulose  % Numeric 5 15 -1 1 10 4.472136 
B Amount of PEG 6000  % Numeric 10 20 -1 1 15 4.472136 
C Spheronization speed rpm Numeric 700 1500 -1 1 1100 357.7709 
D Croscarmellose sodium % Numeric 1 3 -1 1 2 0.894427 
All values represent mean±standard deviation (n=3) 
 
Theoretical yield 
Correlation of Theoretical Yield with Amount of Methyl Cellulose (-
0.396), Amount of PEG 6000 (-0.543), Spheronization speed (-0.364) 
and Croscarmellose sodium (0.190) was shown in fig. 1. Amount of 
Methyl Cellulose, Amount of PEG 6000, Spheronization speed rate 
shows negative correlation as Amount of Croscarmellose sodium 
shows a positive correlation. 
 
 
Fig. 1: Response surface graph for theoretical yield with respect to the amount of PEG 6000 and methylcellulose as prominent factors 
 
From this, it was concluded that there was a negative effect of 
Amount of Methyl Cellulose, Amount of PEG 6000, Spheronization 
speed rate and positive effect of Croscarmellose sodium on the 
Theoretical Yield. Final Equation in Terms of Coded Factors:  
Theoretical Yield = 59.16667-8.33333 * A-11.4167 * B-7.66667* C+4 
* D+4.625 * A * B+4.75 * A * C-1.625 * A * D-3.75 * B * C-0.625 * B * 
D-5 * C * D-0.0625 * A2-4.9375 * B2-1.4375 * C2-1.3125 * D2 
Mean pellet size 
Correlation of mean pellet size with the amount of Methyl Cellulose 
(0.571), amount of PEG 6000 (0.359), Spheronization speed (0.079) 
and Croscarmellose sodium (-0.091) was shown in fig. 2. Amount of 
Methyl Cellulose, Amount of PEG 6000, Spheronization speed rate 
shows positive correlation as Amount of Croscarmellose sodium 
shows a negative correlation. 
  
 
Fig. 2: Response surface graph for mean pellet size with respect to amount of PEG 6000 and methylcellulose as prominent factors 
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From this, it was concluded that there was a positive effect of 
Amount of Methyl Cellulose, Amount of PEG 6000, Spheronization 
speed rate and negative effect of Croscarmellose sodium on the 
mean pellet size. In this case, A and B are significant model terms. 
Final Equation in Terms of Coded Factors:  
Mean Pellet size = 1261+200.5416667 * A+126.0416667 * 
B+27.70833333 * C-31.875 * D+61.3125 * A * B+44.5625 * A * C-
15.8125 * A *D+84.1875 * B * C+62.8125 * B * D-20.1875 * C * D-
50.07291667 * A2-68.94791667 * B2-69.19791667*C2-
89.19791667 * D2 
Sphericity (pellips) 
Correlation of Sphericity with Amount of Methyl Cellulose (-
0.080), Amount of PEG 6000 (-0.248), Spheronization speed (-
0.623) and Croscarmellose sodium (0.235) was shown in fig. 3. 
Amount of Methyl Cellulose, Amount of PEG 6000, Spheronization 
speed rate shows negative correlation as Amount of 
Croscarmellose sodium shows a positive correlation. From this, it 
was concluded that there was a negative effect of Amount of 
Methyl Cellulose, Amount of PEG 6000, Spheronization speed rate 
and positive effect of Croscarmellose sodium on the Sphericity. In 
this case, CandC2 are significant model terms. Final Equation in 
Terms of Coded Factors:  
Sphericity (pellips) =1.241-0.045375 * A-0.140041667 * B-
0.352041667 * C+0.132541667 * D-0.0184375 * A * B-0.0028125 * 
A * C+0.0421875 * A * D+0.0789375 * B * C+0.1729375 * B * D-
0.1801875 * C * D+0.036739583* A2+0.024989583 
*B2+0.150114583 * C2-0.072760417 * D2 
 
 
Fig. 3: Response surface graph for sphericity (pellips) with respect to the Amount of PEG 6000 and Methylcellulose as prominent factors 
 
Friability 
Correlation of Friability with Amount of Methyl Cellulose (-0.139), 
Amount of PEG 6000 (-0.425), Spheronization speed (-0.569) and 
Croscarmellose sodium (-0.083) was shown in fig. 4. Amount of 
Methyl Cellulose, Amount of PEG 6000, Spheronization speed rate 
and Amount of Croscarmellose shows a negative correlation. From 
this, it was concluded that there was a negative effect of Amount of 
Methyl Cellulose, Amount of PEG 6000, Spheronization speed rate 
and Croscarmellose sodium on the Friability. In this case, B and C 
are significant model terms. Final Equation in Terms of Coded 
Factors:  
Friability =0.977666667-0.090041667 * A-0.276458333 * B-
0.369791667 * C-0.053875 * D-0.0499375 * A * B+0.1444375 * A * 
C+0.1908125 * A * D-0.0159375 * B * C-.2048125 * B * D+0.0333125 
* C * D+0.05140625 * A2+0.00440625 * B2-0.03796875 * C2-
0.13721875 * D2. 
 
 
Fig. 4: Response surface graph for friability with respect to Amount of PEG 6000 and Methylcellulose as prominent factors 
Sathesh et al. 




Correlation of Porosity with Amount of Methyl Cellulose (-0.396), 
Amount of PEG 6000 (-0.543), Spheronization speed (-0.364) and 
Croscarmellose sodium (0.190 was shown in fig. 5. Amount of 
Methyl Cellulose, Amount of PEG 6000, Spheronization speed rate 
shows negative correlation as Amount of Croscarmellose sodium 
shows a positive correlation. From this, it was concluded that there 
was a negative effect of Amount of Methyl Cellulose, Amount of PEG 
6000, Spheronization speed rate and positive effect of 
Croscarmellose sodium on the Porosity. In this case, D is a significant 
model term. Final Equation in Terms of Coded Factors:  
Porosity = 3.533333333+0.282916667 * A-0.12375* 
B+0.142916667 * C+2.037083333 * D+0.068125 * A * B-0.136875 * 
A * C-0.051875 * A * D+0.091875 * B * C-0.388125 * B * D-0.133125 




Fig. 5: Response surface graph for porosity with respect to amount of PEG 6000 and methylcellulose as prominent factors 
 
Mechanical crushing force  
Correlation of Mechanical crushing force with Amount of Methyl 
Cellulose (0.338), Amount of PEG 6000 (-0.243), Spheronization 
speed (-0.238) and Croscarmellose sodium (-0.161) was shown in 
fig. 6. Amount of Croscarmellose sodium, Amount of PEG 6000, 
Spheronization speed rate shows negative correlation as Amount of 
Methyl Cellulose shows a positive correlation. From this, it was 
concluded that there was a negative effect of Amount of 
Croscarmellose sodium, Amount of PEG 6000, Spheronization speed 
rate and positive effect of Amount of Methyl Cellulose on the 
Mechanical crushing force. The cubic model was aliased. In this case, 
A, AD, BC is a significant model terms. Final Equation in Terms of 
Coded Factors:  
Mechanical crushing force = 3.787666667+0.769166667 * A-
0.5525* B+0.541666667* C-0.3675 * D+0.23125 * A * B+0.16 * A * C-
1.03125 * A * D-1.2125 * B * C-0.29625* B D-0.0875 * C * D 
 
 
Fig. 6: Response surface graph for mechanical crushing force with respect to amount of PEG 6000 and methylcellulose as prominent 
factors 
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Drug release  
The in vitro drug release data from the different formulations were 
evaluated kinetically using the Korsmeyer-Peppas, Weibull and Hixson-
Crowell models. The coefficient of determination (R2), root-mean-
square error (RMSE) and Akaike's information criterion (AIC) values of 
these models were determined for evaluation of accuracy and prediction 
ability of these models using Kinet DS 3.0 rev. 2010 software (Krakow, 
Poland). From the obtained results, it is observed that for all 
formulations the drug release mechanism is best described by 
Korsmeyer-Peppas model. The release exponent (n) is used in order to 
characterize different release mechanism. Correlation of Dissolution 
efficiency with Amount of Methyl Cellulose (0.277), Amount of PEG 6000 
(0.383), Spheronization speed (0.022) and Croscarmellose sodium (-
0.036) was shown in fig. 7. Amount of Methyl Cellulose, amount of PEG 
6000 and Spheronization speed rate shows positive correlation as 
Amount of Croscarmellose sodium shows a negative correlation. From 
this, it was concluded that there was a positive effect of Amount of, 
Amount of PEG 6000, Spheronization speed rate and negative effect of 
Croscarmellose sodium on the Dissolution efficiency. The cubic model 
was aliased. In this case, B, A2, B2, C2 are significant model terms. Final 
Equation in Terms of Coded Factors:  
Dissolution Efficiency =+77.52+2.05 * A+2.83 * B+0.16 * C-0.26 * 
D+2.08 * A * B-1.18 * A * C+0.66 * A * D+0.32 * B * C-0.59 * B * D-
2.58 * C * D-2.85 * A2-2.48 * B2-2.14 * C2+0.29 * D2 
 
 
Fig. 7: Response surface graph for dissolution efficiency with respect to amount of PEG 6000 and methylcellulose as prominent factors 
 
Release kinetic  
Fig. 8 shows in vitro drug release of all formulations. The 
correlation coefficient (𝑅2) was found to be in between (𝑅2) = 
0.997 to 0.999. By observing the regression values of various 
models, the Korsmeyer-Peppas with a lag model was found to be 
the best model for all formulation. The value of n in our 
formulations is between 0.77+0.04 which characterizes the 




Fig. 8: Cumulative % drug release studies of formulations (F1 to F30) 
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Table 3: Summary of results of various micromeritic evaluation parameters and drug content of optimized immediate release pellets 
prepared 
Evaluation parameter Pellets±SD* 
Bulk density (g/cm3) 0.4928±0.0505 
Tapped density (g/cm3) 0.8333±0.0396 
Carr’s index (% compressibility) 11.2179±0.6202 
Hausner’s ratio (RH) 23.0733±0.3847 
Angle of repose (degree) 27.8215±0.6161 
Drug content (%) 97.1±1.80 
 *All values represent mean±standard deviation (n=3) 
 
Results of various micromeritic evaluation parameters and drug 
content of optimized immediate release pellets prepared are 
summarized in table 3. 
Experimental parameters 
The extruder used is of the axial-type single-screw feeder and hence 
generates heat due to the friction of the screw feeder with the wall 
of the extruder. Thus, varying the speed of the extruder to either 
medium or low resulted in drying of the wet blend within the 
extruder. Hence, the speed of extruder was fixed at maximum for a 
better output of extrusion. In this study, during preliminary trials, it 
was observed that initial high-speed spheronization is required to 
reduce the length of extrudes, but if the same speed is continued 
further, a greater amount of fines were generated. Hence, to reduce 
the generation of fines and achieve spherical pellets, spheronization 
speed and time could not be fixed at one value. Initial high speed 
followed by medium speed, enough to round off extrudes, was 
applied to manufacture pellets. The inability of extrudes to break at 
low spheronization speed can be the result of high drug content in 
wet mass. Moreover, the time required to spheronize the same was 
also higher than usual processing owing to less percent w/w of MCC 
in the formulation. It took more time to spheronize the cut extrudes 
with varying speed during the process. Moreover, high drug loading 
resulted in granules which were difficult to extrude when extrusion 
screen below 1 mm was used. Higher screen size resulted in high 
pellet diameter, and thus the extruder screen was fixed to 1 mm. 
Excipients effect 
A spheronizing agent, such as a suitable grade of microcrystalline 
cellulose (MCC), is required to produce spherical pellets. MCC, being 
a spheronizing aid, highly affects sphericity along with a granulating 
solvent, i.e., water, which acts as a plasticizer. Hence, from 
preliminary trials, a minimum amount of MCC was identified which 
is required to impart sphericity to pellets, and disintegrants were 
added in order to improve the disintegration of pellets [20, 21]. PEG 
6000, being a binder, highly affected the friability and disintegration 
of pellets. Cross carmellose sodium, used as a super disintegrant, 
affected friability and disintegration time. During extrusion and 
spheronization, swelling of CCS was observed which was directly 
proportional to the quantity of CCS used in the formulation. The 
greater the proportion of CCS used, the greater the swelling, which 
finally led to the generation of more amount of fines during 
spheronization, irrespective of binder concentration. Moreover, it 
also reduced the disintegrant property of CCS when such batches 
were evaluated for DT. Thus, considering these effects, its range was 
fixed and the risk was mitigated [22]. 
Validation of multiple response optimization models 
The formulation parameters of the optimum and the random 
checkpoints, their experimental and predicted values for all the 
seven response variables are listed in table 4. The optimized 
Immediate release pellets were prepared with Amount of Methyl 
Cellulose (7.9%), Amount of PEG 6000 (10%), Spheronization speed 
(1492rpm) and Croscarmellose sodium (2.83%). The optimized 
immediate release pellets were evaluated for all the 
physicomechanical properties using the methods mentioned earlier. 
The summary of the results of various physicomechanical evaluation 
parameters and drug content of immediate-release pellets are 
shown in table 4. The experimental and predicted values for all the 
seven responses (Y1 to Y7) along with percentage prediction error* 
observed for optimum formulation (A) and random formulation (B 
and C). 
 
Table 4: Percent prediction error (PE) was calculated using the formula (Experimental Value–Predicted Value)/Experimental Value) x 100 
















63.89 63.30 0.92346 50.61 50.43 0.35566 58.94 58.51 0.7295555 
Mean Pellet size 707.85 706.36 0.2105 945.77 945.01 0.08036 886.99 886.91 0.0090193 
Sphericity 
(pellips) 
0.901 0.90 0.11099 0.978 0.97 0.818 0.999 0.99 0.9009009 
Friability 0.836 0.83 0.7177 1.199 1.19 0.75063 0.968 0.96 0.8264463 
Porosity 5.927 5.92 0.1181 5.737 5.73 0.12201 5.288 5.26 0.5295008 
Mechanical 
crushing force  
6.01 6 0.16639 6.02 6 0.33223 6.04 6 0.6622517 
Dissolution 
Efficiency 
68.17 68.10 0.10268 65.32 65.11 0.32149 68.93 68.72 0.3046569 
*#The values represented in the brackets are the Amount of Methyl Cellulose, Amount of PEG 6000, Spheronization speed and Croscarmellose 
sodium, respectively for A, B and C formulations  
 
Compatibility study 
Fourier transform infrared spectroscopy (FT-IR) 
FT-IR spectra of formulation showed the presence of all the principal 
peaks corresponding to the drug and polymers, they were with 
reduced transmittance and broader compared to those observed in 
the individual spectra. In addition, characteristic peak at 3, 435 cm-1 
correspondings to free O-H stretching vibrations characteristic of a 
crystalline form of the drug was found to be absent in FT-IR spectra of 
the pellet. Presence of broadened principal peaks in FT-IR spectra with 
reduced transmittance suggested conversion of a crystalline form of 
the drug to amorphous form in extruded pellets. Similar observations 
were reported by Kim et al., 2008 also in the characterization of the 
crystalline and amorphous form (fig. 9) [23]. 
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Fig. 9: FTIR spectra of A) Tamoxifen Citrate B) PEG 6000 C) Methyl Cellulose and D) Pellets 
 
Differential scanning calorimetry (DSC) 
In DSC study, there is the minor shifting of melting endotherm of the 
drug; hence it can be said that, there was no incompatibility of drug 
with any of the excipients [25, 26] (fig. 10). 
X-ray powder diffraction (XRPD) 
A distinct halo pattern and absence of principal diffraction peaks 
characteristic of crystalline TMC in XRPD profile of pellets confirmed 
that the drug was molecularly dispersed in the polymer matrix and 
the extrudates, so formed were homogeneous, amorphous solid 
solution system; supporting the predictions of thermal analysis. 
Whereas for broadened principal diffraction peaks suggested very 
fine ‘crystallites' of the drug in the polymeric matrix and hence there 
was an insignificant degree of residual crystallinity in the 
extrudates. [27] Further, no new peaks could be observed, 
suggesting the absence of interaction between the drug and the 
carrier (fig. 11). 
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Fig. 10: DSC thermograph of A) Tamoxifen citrate B) PEG 6000 C) citric acid, D) methylcellulose E) microcrystalline cellulose and F) 
extruded pellets 
 
Scanning electron microscopy (SEM) 
Tamoxifen citrate 12a appeared as dense and agglomerate crystal. 
However, the photomicrographs extruded pellets (12b, 12c, and 
12d) appeared as spherical shape. These photomicrographs 
showed an absence of crystals of TMC as an entity and the 
particles rather appeared to be homogeneous. Dense, 
homogeneous appearance and absence of agglomerated crystals of 
TMC as an entity suggested uniform dispersions of TMC molecules 
into the extruded pellets [27]. 
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Fig. 11: X-ray diffraction patterns of A) TMX B) MCC C) PEG 6000 D) methyl cellulose and E) pellets 
 
 
Fig. 12: SEM images of TMX (12a) and pellets (12b, c and d) 
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Accelerated stability studies 
The optimized immediate release pellets were subjected to 
accelerated stability studies (40 °C±2 °C/75% RH±5%) for 6 mo. 
Stability of immediate release pellets was also studied at room 
temperature for 6M. The samples were withdrawn from both the 
stability conditions at 1 M, 2 M, 3 M and 6 M. The samples were 
analyzed for their drug content and dissolution profile (table 5). The 
drug content of the immediate release pellets on stability ranged 
from 98.23-100.54%. Almost constant drug content within 
Pharmacopoeial limits (95%-105% w/w) indicates that immediate 
release pellets are stable till 6M at room temperature and at 
accelerated stability conditions. To asses change in release profile 
statistically, similarity factor (f2) was calculated. Similarity factor is 
a fit factor which is essentially a quantitative method, that reflects 
the differences between the two release curves. The f2 or similarity 
factor of immediate release pellets was found to be>90 for all the 
stability samples with respect to their initial release profile. This 
indicates that the release pattern of immediate release pellets is not 
affected by the stability conditions fig. 13. 
  
Table 5: Assay stability samples immediate release pellets at 1 M, 2 M, 3 M, and 6 M 
Parameter Duration 40 °C±2 °C/75% RH±5% At room temperature 
HDPE Alu. strip HDPE Alu. strip 
Assay 
(%) 
1 mo 98.35±1.30 99.57±1.85 98.86±1.33 99.74±1.86  
2 mo 99.25±1.25 98.99±1.62 99.65±1.41 101.02±1.36 
3 mo 100.45±1.41 100.26±1.23 100.54±1.28 99.47±1.42 
6 mo 98.23±1.45 99.26±1.52 99.62±1.22 98.87±1.31 
*All values represent mean±standard deviation (n=3) 
 
 
Fig. 13: Dissolution profile of initial, 3 Mo and 6 Mo stability sample of tamoxifen citrate immediate release pellets 
 
In vitro cell cytotoxicity and viability assay 
Reduced apoptosis was observed for optimized immediate release 
pellets on MCF-7 cells, which may be due to the fact that the anti-
apoptotic factor Bcl-2 (B Cell Lymphoma-2) was overexpressed and 
caspase-3 is a major component of the effector phase of the majority 
of apoptotic signaling pathways, was not expressed. Therefore, the 
optimized immediate release pellets demonstrated less toxicity on 
MCF-7 cells [28]. 
Another observation made in case of MTT results of MCF-7 cells 
mentioning is that the optimized immediate release pellets show 
maximum cytotoxicity at 80 µg/ml on MCF-7 cell lines as can be 
observed from the (fig. 14, 15, 16). 
The cytotoxicity at 80 µg/ml concentration was 37.13% for MCF-7 
cells. This may be due to facilitated uptake of a drug at these 
concentrations, which results in more drug molecules to be 
available inside the cell, hence leading to increased cytotoxicity. 
MWCNTs-cell membrane interaction could also affect cellular 
response and cytotoxicity, the higher toxicity exhibited by 
optimized immediate release pellets at higher concentrations (viz. 
100 µg/ml) may be due to the aggregation of the drug at this 
concentration which could impair the plasma membrane, leading 
to cell death. This explains the reason for enhanced cytotoxicity of 
the optimized immediate release pellets at 80 µg/ml rather than at 
100 µg/ml (table 6). 
 
Table 6: % Cell viability and % cell cytotoxicity at different (1 to 100 µg/ml) concentrations on MCF-7 cell lines 
Group O. D. Mean±SD* % Viability % Cytotoxicity 
Vehicle Control 0.060 0.036 0.082 0.059±0.023 - - 
Control 0.149 0.132 0.115 0.132±0.017 - - 
1µg/ml 0.137 0.123 0.106 0.122±0.016 92.42±1.21 07.58±0.098 
10µg/ml 0.105 0.127 0.111 0.114±0.011 86.36±1.15 13.64±0.025 
20µg/ml 0.106 0.102 0.105 0.104±0.002 78.78±1.51 21.22±0.032 
40µg/ml 0.099 0.092 0.095 0.095±0.006 71.96±0.98 28.04±0.041 
80µg/ml 0.088 0.077 0.081 0.082±0.004 62.87±1.32 37.13±0.022 
100µg/ml 0.096 0.088 0.092 0.092±0.006 69.69±0.96 30.31±0.012 
*All values represent mean±standard deviation (n=3) 
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Fig. 14: Inverted Microscopic Images of MCF-7 Cells at 0 D (A) 
Control-1, (B) Control-2, (C) 1µg/ml, (D) 10 µg/ml, (E) 20 
µg/ml, (F) 40 µg/ml, (G) 80 µg/ml, (H) 100 µg/ml 
 
 
Fig. 15: Inverted Microscopic Images of MCF-7 Cells treated with 
optimised immediate release pellets after 24 h. (A) Control-1, 
(B) Control-2, (C) 1µg/ml, (D) 10 µg/ml, (E) 20 µg/ml, (F) 40 
µg/ml, (G) 80 µg/ml, (H) 100 µg/ml 
 
Fig. 16: Inverted Microscopic Images of MCF-7 Cells treated with 
after addition of MTT (A) Control-1, (B) Control-2, (C) 1µg/ml, 




The present study concluded that PEG 6000 and methylcellulose 
(MC) can effectively improve the dissolution behavior of tamoxifen 
citrate. The study also concluded that there is a positive effect of the 
amount of PEG 6000, Spheronization speed rate and negative effect 
of the amount of PEG Croscarmellose sodium on the dissolution 
efficiency. The results of the present study showed that hot-melt 
extrusion method and materials i.e. PEG 6000 and methylcellulose 
(MC) can constitute an excellent alternative to conventional 
polymers. The HME technique can be a proficient, environmental 
friendly and cost-effective tool for formulating pellets of immediate 
release drug delivery system. 
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